Screener
Ovid Therapeutics OVID Q4 2025 Annual earnings
Reported March 18, 2026 · Before market open
Revenue$718.0KBeat by $639.8K
EPS$0.06Beat by $0.16
Revenue estimate$78.3K
EPS estimate-$0.10
Next report
Nov 11, 2026 (In 1 week)Revenue estimate$31.1K
EPS estimate-$0.08
Versus estimates
Revenue
Q2 2026$733.0KBeat by $711.6K
Q4 2025$718.0KBeat by $639.8K
Q3 2025$132.0KBeat by $69.4KQ2 2025$6.3MBeat by $6.2MQ1 2025$130.0KBeat by $87.5KDiluted EPS
FAQ
- When did Ovid Therapeutics report Q4 2025 earnings?
- Ovid Therapeutics (OVID) reported Q4 2025 earnings on March 18, 2026 before market open.
- What were Ovid Therapeutics's Q4 2025 revenue and EPS?
- Ovid Therapeutics reported revenue of $718.0K and eps of $0.06 for Q4 2025.
- Did Ovid Therapeutics beat estimates in Q4 2025?
- Revenue beat the consensus estimate of $78.3K by $639.8K. EPS beat the consensus estimate of $-0.10 by $0.16.
- How did Ovid Therapeutics's Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 844.7% from $76.0K a year earlier.
- Where can I find Ovid Therapeutics's Q4 2025 SEC filings?
- You can read the 8-K earnings release (0001628280-26-019045) and the 10-K periodic report (0001628280-26-019438) directly on SEC EDGAR. The filing index links above go to sec.gov.
